Issue 6/2016
Content (8 Articles)
Editorial
Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective
Kenneth Boyd, Peter Hall
Systematic Review
Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension
Shuyan Gu, Huimei Hu, Hengjin Dong
Systematic Review
Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
Jagpreet Chhatwal, Tianhua He, Maria A. Lopez-Olivo
Systematic Review
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus
Martin Henriksson, Ramandeep Jindal, Catarina Sternhufvud, Klas Bergenheim, Elisabeth Sörstadius, Michael Willis
Review Article
Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence
Sebastian Hinde, Ros Wade, Stephen Palmer, Nerys Woolacott, Eldon Spackman
Open Access
Current Opinion
Biosimilars: How Can Payers Get Long-Term Savings?
Jorge Mestre-Ferrandiz, Adrian Towse, Mikel Berdud
Original Research Article
Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers’ Submissions to the French National Authority for Health
Salah Ghabri, Françoise F. Hamers, Jean Michel Josselin